These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31481068)

  • 1. Needle exchange programmes in Visegrad countries: a comparative case study of structural factors in effective service delivery.
    Kender-Jeziorska I
    Harm Reduct J; 2019 Sep; 16(1):54. PubMed ID: 31481068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legislative Norms to Control Cannabis Use in the Light of Its Prevalence in Czech Republic, Poland, Slovakia, and Hungary.
    Čecho R; Baška T; Švihrová V; Hudečková H
    Cent Eur J Public Health; 2017 Dec; 25(4):261-265. PubMed ID: 29346846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Realization of the EU's Cohesion Policy in Health Care in the Visegrad Group Countries in the Perspective 2014-2020.
    Holecki T; Kowalska-Bobko I; Fraczkiewicz-Wronka A; Wegrzyn M
    Front Public Health; 2020; 8():133. PubMed ID: 32391306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review.
    Tichopád A; Müllerová J; Jackowska T; Nemes E; Pazdiora P; Sloesen B; Štefkovičová M
    Value Health Reg Issues; 2016 Sep; 10():53-60. PubMed ID: 27881278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [International Comparison of Health System Performance in Visegrad Countries].
    Dlouhý M
    Cas Lek Cesk; 2016; 155(5):242-246. PubMed ID: 27696886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health policy in Eastern Europe: a comparative analysis of seven mental health systems.
    Dlouhy M
    BMC Health Serv Res; 2014 Jan; 14():42. PubMed ID: 24467832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state and prospects of biotechnology in Central and Eastern European countries. Part I: Visegrad countries (CZ, H, PL, SK).
    Dettenhofer M; Ondrejovič M; Vásáry V; Kaszycki P; Twardowski T; Stuchlík S; Turňa J; Dundar M; Gartland KMA; Miertuš S
    Crit Rev Biotechnol; 2019 Feb; 39(1):114-136. PubMed ID: 30372626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
    Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
    Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of tobacco consumption in Croatia--are we successfully facing the epidemic?
    Padjen I; Dabić M; Glivetić T; Biloglav Z; Biočina-Lukenda D; Lukenda J
    Cent Eur J Public Health; 2012 Mar; 20(1):5-10. PubMed ID: 22571009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nowcasting unemployment rates with Google searches: evidence from the Visegrad Group countries.
    Pavlicek J; Kristoufek L
    PLoS One; 2015; 10(5):e0127084. PubMed ID: 26001083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance.
    Smith K; Bartlett N; Wang N
    Int J Drug Policy; 2012 Jul; 23(4):327-32. PubMed ID: 22377341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental tobacco smoke of youngsters in Czech Republic, Hungary, Poland and Slovakia--findings from the Global Youth Tobacco Survey (GYTS).
    Baska T; Sovinová H; Németh A; Prewozniak K; Warren CW; Baskova M;
    Int J Public Health; 2007; 52(1):62-6. PubMed ID: 17966821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic Food in the Diet of Residents of the Visegrad Group (V4) Countries-Reasons for and Barriers to Its Purchasing.
    Soroka A; Mazurek-Kusiak AK; Trafialek J
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
    Matheson C; Bond CM; Tinelli M
    J Public Health (Oxf); 2007 Dec; 29(4):350-7. PubMed ID: 17986490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
    Bonny-Noach H
    Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Select barriers to harm-reduction services for IDUs in eastern Europe.
    Curth NK; Hansson LN; Storm F; Lazarus JV
    Cent Eur J Public Health; 2009 Dec; 17(4):191-7. PubMed ID: 20377047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.